MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
0.6836
-0.0332 (-4.63%)
At close: Mar 27, 2026, 4:00 PM EDT
0.6800
-0.0036 (-0.53%)
After-hours: Mar 27, 2026, 6:42 PM EDT
MaxCyte Employees
MaxCyte had 91 employees as of December 31, 2025. The number of employees decreased by 23 or -20.18% compared to the previous year.
Employees
91
Change (1Y)
-23
Growth (1Y)
-20.18%
Revenue / Employee
$362,923
Profits / Employee
-$490,440
Market Cap
73.05M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 91 | -23 | -20.18% |
| Dec 31, 2024 | 114 | -29 | -20.28% |
| Dec 31, 2023 | 143 | 18 | 14.40% |
| Dec 31, 2022 | 125 | 41 | 48.81% |
| Dec 31, 2021 | 84 | 19 | 29.23% |
| Mar 31, 2021 | 65 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Neuronetics | 658 |
| Treace Medical Concepts | 450 |
| Outset Medical | 310 |
| Xtant Medical Holdings | 232 |
| Baird Medical Investment Holdings | 143 |
| LENSAR | 140 |
| Picard Medical | 75 |
| Sera Prognostics | 72 |
MXCT News
- 4 days ago - MaxCyte, Inc. (MXCT) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - MaxCyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance - GlobeNewsWire
- 6 days ago - MaxCyte Appoints Parmeet Ahuja as Chief Financial Officer - GlobeNewsWire
- 4 weeks ago - MaxCyte unveils ExPERT DTx™, a 96-well electroporation platform to accelerate discovery - GlobeNewsWire
- 4 weeks ago - MaxCyte to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026 - GlobeNewsWire
- 2 months ago - MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 4 months ago - Cellares Appoints Former MaxCyte Commercial Chief Ali Soleymannezhad as Chief Commercial Officer to Lead Global IDMO Expansion, Catalyze Next Wave of Partnerships, Prepare for IPO - Business Wire
- 4 months ago - MaxCyte, Inc. (MXCT) Q3 2025 Earnings Call Transcript - Seeking Alpha